Načítá se...
Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies
BACKGROUND: Attenuated oncolytic measles virus (OMV) is a promising antitumor agent in early-phase clinical trials. However, pre-existing immunity against measles might be a hurdle for OMV therapy. METHODS: OMV was inactivated with short-wavelength ultraviolet light (UV-C). Loss of replication and o...
Uloženo v:
| Vydáno v: | Oncolytic Virother |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933358/ https://ncbi.nlm.nih.gov/pubmed/29750140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S150637 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|